Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen, Darren A.E. Cross, Pasi A. Jänne
Topics & Concepts
ImatinibDrug discoveryDrugMedicineImatinib mesylatePharmacologyBioinformaticsCancer researchBiologyMyeloid leukemiaChronic Myeloid Leukemia TreatmentsHER2/EGFR in Cancer ResearchPI3K/AKT/mTOR signaling in cancer